Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine Reductase Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120574796A enables high-purity (S)-nornicotine production. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN118909993A reveals a high-activity imine reductase mutant for green synthesis. Achieves >99% optical purity and high space-time yield for reliable supply.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.